Cargando…

Evaluation of the accuracy of the PLCO(m2012) 6-year lung cancer risk prediction model among smokers in the CARTaGENE population-based cohort

BACKGROUND: The PLCO(m2012) prediction tool for risk of lung cancer has been proposed for a pilot program for lung cancer screening in Quebec, but has not been validated in this population. We sought to validate PLCO(m2012) in a cohort of Quebec residents, and to determine the hypothetical performan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jantzen, Rodolphe, Ezer, Nicole, Camilleri-Broët, Sophie, Tammemägi, Martin C., Broët, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095260/ https://www.ncbi.nlm.nih.gov/pubmed/37041013 http://dx.doi.org/10.9778/cmajo.20210335

Ejemplares similares

Quantifying the Predictive Accuracy of a Polygenic Risk Score for Predicting Incident Cancer Cases : Application to the CARTaGENE Cohort
por: Duhazé, Julianne, et al.
Publicado: (2020)

Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE
por: Jantzen, Rodolphe, et al.
Publicado: (2021)

Epidemiological characteristics of the COVID-19 spring outbreak in Quebec, Canada: a population-based study
por: Jantzen, Rodolphe, et al.
Publicado: (2021)

Socio-Demographic Factors Associated With COVID-19 Vaccine Hesitancy Among Middle-Aged Adults During the Quebec's Vaccination Campaign
por: Jantzen, Rodolphe, et al.
Publicado: (2022)

Prediction of Cardiovascular Events by Pulse Waveform Parameters: Analysis of CARTaGENE
por: Desbiens, Louis‐Charles, et al.
Publicado: (2022)

Mental health, cancer risk, and the mediating role of lifestyle factors in the CARTaGENE cohort study
por: Gilham, Kaitlyn, et al.
Publicado: (2023)

Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis
por: Broët, Philippe, et al.
Publicado: (2009)

Is there an agreement between self-reported medical diagnosis in the CARTaGENE cohort and the Québec administrative health databases?
por: Payette, Y, et al.
Publicado: (2020)

Green space associations with mental health and cognitive function: Results from the Quebec CARTaGENE cohort
por: Hystad, Perry, et al.
Publicado: (2019)

Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort
por: Jantzen, Rodolphe, et al.
Publicado: (2021)

Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
por: Tammemägi, Martin C., et al.
Publicado: (2014)

Relationships between Obesity and Incidence of Fractures in a Middle‐Aged Population: A Study from the CARTaGENE Cohort
por: Turcotte, Anne‐Frédérique, et al.
Publicado: (2023)

Genomic Aberrations in Lung Adenocarcinoma in Never Smokers
por: Job, Bastien, et al.
Publicado: (2010)

A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases
por: Hässler, Signe, et al.
Publicado: (2022)

Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma
por: Dalmasso, Cyril, et al.
Publicado: (2015)

Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial
por: Guertin, Kristin A., et al.
Publicado: (2015)

HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients
por: Tuefferd, Marianne, et al.
Publicado: (2007)

A model-based statistic for detecting molecular markers associated with complex survival patterns in early-stage cancer
por: Broët, Philippe, et al.
Publicado: (2012)

Bagging survival tree procedure for variable selection and prediction in the presence of nonsusceptible patients
por: Mbogning, Cyprien, et al.
Publicado: (2016)

CXCL12 expression by healthy and malignant ovarian epithelial cells
por: Machelon, Véronique, et al.
Publicado: (2011)

Correction: Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Publicado: (2015)

Identifying common prognostic factors in genomic cancer studies: A novel index for censored outcomes
por: Rouam, Sigrid, et al.
Publicado: (2010)

A pseudo-R(2 )measure for selecting genomic markers with crossing hazards functions
por: Rouam, Sigrid, et al.
Publicado: (2011)

Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study
por: Makkar, Rishi, et al.
Publicado: (2020)

Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme
por: Lebrett, Mikey B, et al.
Publicado: (2020)

Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)
por: Elie, C, et al.
Publicado: (2004)

A constrained polynomial regression procedure for estimating the local False Discovery Rate
por: Dalmasso, Cyril, et al.
Publicado: (2007)

A Rescue Strategy for Handling Unevaluable Patients in Simon’s Two Stage Design
por: Belin, Lisa, et al.
Publicado: (2015)

A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up
por: Belin, Lisa, et al.
Publicado: (2017)

Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort
por: Hashibe, Mia, et al.
Publicado: (2015)

A novel tree-based procedure for deciphering the genomic spectrum of clinical disease entities
por: Mbogning, Cyprien, et al.
Publicado: (2014)

A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology
por: Jonas, Sarah Flora, et al.
Publicado: (2017)

Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort
por: Zheng, Rui, et al.
Publicado: (2018)

Detection method has independent prognostic significance in the PLCO lung screening trial
por: Long, James P., et al.
Publicado: (2023)

ExoCarta 2012: database of exosomal proteins, RNA and lipids
por: Mathivanan, Suresh, et al.
Publicado: (2012)

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
por: Shebl, F M, et al.
Publicado: (2012)

Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial
por: He, Shisi, et al.
Publicado: (2022)

A mixture model approach to multiple testing for the genetic analysis of gene expression
por: Dalmasso, Cyril, et al.
Publicado: (2007)

Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma
por: Grenier, Karl, et al.
Publicado: (2023)

Integrative Genomic Analysis Reveals Extended Germline Homozygosity with Lung Cancer Risk in the PLCO Cohort
por: Orloff, Mohammed S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_98526i96mips0gf0a7hsinbuu6